Ethyl Salicylate

Ethyl Salicylate

SCHEMBL982275

CCOC(=O)c1ccccc1O.[GaH3]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.74
TDP1 Q9NUW8 2/20 0.65
CA12 O43570 3/20 0.63
CA1 P00915 3/20 0.63
CA2 P00918 3/20 0.63
CA7 P43166 3/20 0.63
CA9 Q16790 3/20 0.63
CA14 Q9ULX7 3/20 0.63
ALDH1A1 P00352 4/20 0.62
HSD17B10 Q99714 2/20 0.62
SIRT5 Q9NXA8 1/20 0.62
LMNA P02545 2/20 0.60
CDC25B P30305 2/20 0.57
KMT2A Q03164 2/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
RAB9A P51151 2/20 0.52
MEN1 O00255 1/20 0.52
USP2 O75604 1/20 0.52
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Salicylate SCHEMBL982279 1.00 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL1870434 0.98 TSHR (0.77) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL29501114 0.98 TSHR (0.77) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL39622 0.98 TSHR (0.77) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL23045199 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL5709044 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL8191806 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL1640145 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL31585381 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2
Ethyl Salicylate SCHEMBL23803706 0.96 TSHR (0.74) TSHRTDP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140031328-A1 Gallium compounds and methods of use to treat inflammatory bowel disease BERNSTEIN LAWRENCE RICHARD (US) 2014-01-30 US claimed
US-20110021484-A1 Gallium compounds and methods of use to treat inflammatory bowel disease BERNSTEIN LAWRENCE RICHARD 2011-01-27 US claimed
EP-2262509-A2 GALLIUM COMPOUNDS AND METHODS OF USE TO TREAT INFLAMMATORY BOWEL DISEASE Bernstein, Lawrence (US) 2010-12-22 EP claimed
WO-2009111681-A2 GALLIUM COMPOUNDS AND METHODS OF USE TO TREAT INFLAMMATORY BOWEL DISEASE BERNSTEIN LAWRENCE (US) 2009-09-11 WO claimed
US-20140031328-A1 Gallium compounds and methods of use to treat inflammatory bowel disease BERNSTEIN LAWRENCE RICHARD (US) 2014-01-30 US disclosed
US-20110021484-A1 Gallium compounds and methods of use to treat inflammatory bowel disease BERNSTEIN LAWRENCE RICHARD 2011-01-27 US disclosed
EP-2262509-A2 GALLIUM COMPOUNDS AND METHODS OF USE TO TREAT INFLAMMATORY BOWEL DISEASE Bernstein, Lawrence (US) 2010-12-22 EP disclosed
WO-2009111681-A2 GALLIUM COMPOUNDS AND METHODS OF USE TO TREAT INFLAMMATORY BOWEL DISEASE BERNSTEIN LAWRENCE (US) 2009-09-11 WO disclosed